Max has 7+ years of experience in life sciences strategy consulting, working across the pharmaceutical, medtech, and managed care space. Prior to joining Asymmetry Group in 2022, Max was a consultant for ZS Associates in their pipeline & launch strategy vertical, specializing in customer & market insights generation and commercial forecast development. In addition to expertise in market research methodologies and financial modelling, Max has deep experience working as a direct member of his clients’ teams in staff augmentation roles. In those roles, he has worked directly with commercial leadership to design market research & deliver strategic insights, develop & maintain a portfolio of pipeline forecasts, optimize data management, facilitate cross-functional collaboration, and create comprehensive business cases for investment in pipeline assets. Max holds a B.S. in Biology with a minor in Science, Technology & International Affairs from Georgetown University. Outside of work, Max enjoys running, completing NYT crossword puzzles, and chasing snowstorms for his next skiing adventure.
